机译:t(1; 19)(q23; p13)的小儿B细胞前体急性淋巴细胞白血病:按照NOPHO协议治疗的北欧国家47例患者的临床和细胞遗传学特征
Department of Clinical Genetics Rigshospitalet Copenhagen Denmark;
Department of Pathology and Clinical Genetics Haartman Institute University of Helsinki Helsinki Finland;
Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm;
Department of Clinical Genetics Uppsala University Hospital Uppsala;
Department of Medical Biosciences Medical and Clinical Genetics University of Umeå Umeå Sweden;
Section for Cancer Cytogenetics Institute for Medical Informatics The Radium Hospital Oslo University Hospital Oslo;
University of Oslo Oslo Norway;
Chromosome and DNA Laboratory Kuopio University Hospital Kuopio Finland;
Centre for Genetics and Molecular Medicine Haukeland University Hospital Bergen Norway;
Department of Clinical Genetics and Cytogenetics Landspitali University Hospital Reykjavik Iceland;
Department of Clinical Genetics University and Regional Laboratories Skåne University Hospital Lund University Lund Sweden;
The Cancer Cytogenetic Laboratory Department of Haematology Århus University Hospital Århus Denmark;
Department of Clinical Chemistry and Transfusion Medicine University of Gothenburg Gothenburg Sweden;
acute lymphoblastic leukaemia; paediatric; t(1; 19); TCF3; PBX1;
机译:t(1; 19)(q23; p13)的小儿B细胞前体急性淋巴细胞白血病:根据NOPHO协议治疗的北欧国家47例患者的临床和细胞遗传学特征。
机译:ETV6和RUNX1基因的其他畸变对根据NOPHO-ALL-2000协议治疗的229 t(12; 21)(p13; q22)阳性B细胞前体急性淋巴细胞白血病无预后影响
机译:IKZF1缺失在小儿B细胞前体急性淋巴细胞白血病中的临床影响与1992年至2013年间在北欧小儿血液学和肿瘤学治疗方案中使用的最小残留疾病分层无关
机译:高模态数和三重三态性是根据NOPHO ALL 1992/2000协议治疗的儿童B细胞前体高超二倍体急性淋巴细胞白血病中高度相关的有利因素
机译:t(1; 19)(q23; p13)的小儿B细胞前体急性淋巴细胞白血病:根据NOPHO协议治疗的北欧国家47例患者的临床和细胞遗传学特征。